THE FEATURES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE INFLUENCE ON THE PREGNANCY COMPLICATIONS DEVELOPMENT

  • Svitlana Heryak D.Sc, Professor, Head of the Department of Obstetrics and Gynecology No2, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine http://orcid.org/0000-0002-7894-1009
  • Olena Oleksiak PhD student, Assistant Prof. of the Department of Obstetrics and Gynecology No2 I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine https://orcid.org/0000-0001-9767-2695
Keywords: Pregnancy; Chronic Obstructive Pulmonary Disease; Obstetric Complications; Bronchial Obstruction; Cytokines

Abstract

In recent years, the prevalence of chronic obstructive pulmonary disease (COPD) has been increasingly observed among women, which is one of the reasons for the higher interest of scientists in the influence of COPD on pregnant woman.

The aim of our study was to establish the features of the development pregnancy complications in pregnant women with COPD.

Materials and methods. 77 pregnant women with clinically and instrumentally verified signs of COPD were examined and were divided into 2 subgroups depending on the degree of bronchial obstruction: IA - 43 pregnant women with FEV1≥80%, IB - 34 pregnant women with FEV1 50-79%. The control group consisted of 27 healthy pregnant women. The cytokine profile was determined and a correlational interaction with the degree of bronchial obstruction and the frequency of obstetric and perinatal complications was established.

The results. Our analysis of cytokine profile indicators in pregnant women with chronic obstructive pulmonary disease at the stage of mild and moderate bronchial obstruction showed a characteristic and reliable increase in the level of pro-inflammatory cytokines (IL-1β, IL-6) and a simultaneous decrease in the level of anti-inflammatory IL-10 (p≤0.05).

We established that an increase in the degree of bronchial obstruction is also associated with a higher frequency of detection of such pregnancy and childbirth complications as anemia, respectively, by 3.1 times, the threatened of premature birth by 9 times, preeclampsia by 7 times, placental dysfunction by 3.4 times, intrauterine growth restriction 8 times, premature birth 3.5 times, premature rupture of membranes during labor 4 times, and fetal distress 3 times higher compared to the control group.

Conclusions. COPD in pregnant women is characterized by systemic disturbances in the cytokine balance and is accompanied by a significant increase in the frequency of obstetric and perinatal complications, the frequency of which depends on the degree of bronchial obstruction.

References

Aryal, S., Diaz-Guzman, E., & Mannino, D. M. (2014). Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. International journal of chronic obstructive pulmonary disease, 9, 1145. doi: 10.2147/COPD.S54476

Jenkins, C. (2021). Differences between men and women with chronic obstructive pulmonary disease. Clinics in Chest Medicine, 42(3), 443-456. https://doi.org/10.1016/j.ccm.2021.06.001

Gordon, S. B., Bruce, N. G., Grigg, J., Hibberd, P. L., Kurmi, O. P., Lam, K. B. H., ... & Martin II, W. J. (2014). Respiratory risks from household air pollution in low and middle income countries. The Lancet Respiratory Medicine, 2(10), 823-860. https://doi.org/10.1016/S2213-2600(14)70168-7

GBD 2015 Chronic Respiratory Disease Collaborators. (2017). Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. Respiratory Medicine, 5(9), 691. https://doi.org/10.1016/S2213-2600(17)30293-X

Jenkins, C. (2021). Differences between men and women with chronic obstructive pulmonary disease. Clinics in Chest Medicine, 42(3), 443-456. https://doi.org/10.1016/j.ccm.2021.06.001

Tamási, L., Horváth, I., Bohács, A., Müller, V., Losonczy, G., & Schatz, M. (2011). Asthma in pregnancy–immunological changes and clinical management. Respiratory medicine, 105(2), 159-164. https://doi.org/10.1016/j.rmed.2010.11.006

Orru, H., Ebi, K. L., & Forsberg, B. (2017). The interplay of climate change and air pollution on health. Current environmental health reports, 4(4), 504-513. https://doi.org/10.1007/s40572-017-0168-6

Rodriguez, M. E. S., & Silveyra, P. (2022). Air Pollution Exposure as a Relevant Risk Factor for Chronic Obstructive Pulmonary Disease Exacerbations in Male and Female Patients. EMJ. https://doi.org/10.33590/emj/21-00228.

Ali, S., Majid, S., Ali, M. N., Taing, S., Rehman, M. U., & Arafah, A. (2021). Cytokine imbalance at materno-embryonic interface as a potential immune mechanism for recurrent pregnancy loss. International Immunopharmacology, 90, 107118. https://doi.org/10.1016/j.intimp.2020.107118

Obling, N., Backer, V., Hurst, J. R., & Bodtger, U. (2022). Nasal and systemic inflammation in Chronic Obstructive Pulmonary Disease (COPD). Respiratory Medicine, 195, 106774. https://doi.org/10.1016/j.rmed.2022.106774

Mor, G., & Kwon, J. Y. (2015). Trophoblast-microbiome interaction: a new paradigm on immune regulation. American journal of obstetrics and gynecology, 213(4), S131-S137. https://doi.org/10.1016/j.ajog.2015.06.039

Cheng, S. L., Wang, H. C., Yu, C. J., & Yang, P. C. (2008). Increased expression of placenta growth factor in COPD. Thorax, 63(6), 500-506. http://dx.doi.org/10.1136/thx.2007.087155

Silva, B. S., Lira, F. S., Ramos, D., Uzeloto, J. S., Rossi, F. E., Freire, A. P. C., ... & Ramos, E. M. (2018). Severity of COPD and its relationship with IL-10. Cytokine, 106, 95-100. https://doi.org/10.1016/j.cyto.2017.10.018

Huang, A. X., Lu, L. W., Liu, W. J., & Huang, M. (2016). Plasma inflammatory cytokine IL-4, IL-8, IL-10, and TNF-α levels correlate with pulmonary function in patients with asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome. Medical science monitor: international medical journal of experimental and clinical research, 22, 2800. doi:10.12659/MSM.896458

Macnab, W. R. (2022). Functions of the placenta. Anaesthesia & Intensive Care Medicine. https://doi.org/10.1016/j.mpaic.2022.03.003

Žák, P., & Souček, M. (2019). Correlation of tumor necrosis factor alpha, interleukin 6 and interleukin 10 with blood pressure, risk of preeclampsia and low birth weight in gestational diabetes. Physiological Research, 68(3), 395-408. https://doi.org/10.33549/physiolres.934002

Brogin Moreli, J., Cirino Ruocco, A. M., Vernini, J. M., Rudge, M. V. C., & Calderon, I. M. P. (2012). Interleukin 10 and tumor necrosis factor-alpha in pregnancy: aspects of interest in clinical obstetrics. International Scholarly Research Notices, 2012. doi:10.5402/2012/230742

Azizieh, F. Y., & Raghupathy, R. G. (2015). Tumor necrosis factor-α and pregnancy complications: a prospective study. Medical principles and practice, 24(2), 165-170. https://doi.org/10.1159/000369363

Azizieh, F. Y., & Raghupathy, R. (2017). IL-10 and pregnancy complications. Clinical and Experimental Obstetrics & Gynecology, 44(2), 252-258. https://doi.org/10.12891/ceog3456.2017

Khong, Y.T. (2015). Pathology of early pregnancy loss. Keelings Fetal and Neonatal Patholog: Springer International Publishing, 7, 165-181.

Views:

118

Downloads:

92

Published
2022-09-30
Citations
How to Cite
Heryak, S., & Oleksiak, O. (2022). THE FEATURES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE INFLUENCE ON THE PREGNANCY COMPLICATIONS DEVELOPMENT. World Science, (5(77). https://doi.org/10.31435/rsglobal_ws/30092022/7869
Section
Medicine